• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail

Patent and Exclusivity Search Results from query on Appl No 021770 Product 001 in the OB_Rx list.

Patent Data

Appl No Prod No Patent No Patent
Drug Substance
Drug Product
Patent Use
N021770 001 6562873 Jul 10, 2021 Y
N021770 001 6562873*PED Jan 10, 2022
N021770 001 6627210 Jul 18, 2021 Y
N021770 001 6627210*PED Jan 18, 2022
N021770 001 6641834 Jul 28, 2021 Y
N021770 001 6641834*PED Jan 28, 2022
N021770 001 6673337 Jul 26, 2021 Y
N021770 001 6673337*PED Jan 26, 2022
N021770 001 8858961 Sep 2, 2023 Y
N021770 001 8858961*PED Mar 2, 2024

Exclusivity Data

There is no unexpired exclusivity for this product.

Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.

View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through February 2015
Patent and Generic Drug Product Data Last Updated March 27, 2015